THE SHADOW Trademark
Trademark Overview
On Monday, October 22, 1990, a trademark application was filed for THE SHADOW with the United States Patent and Trademark Office. The USPTO has given the THE SHADOW trademark a serial number of 74107962. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Wednesday, July 22, 1992. This trademark is owned by SciMed Life Systems, Inc.. The THE SHADOW trademark is filed in the Medical Instrument Products category with the following description:
angioplasty balloon catheters
General Information
| Serial Number | 74107962 |
| Word Mark | THE SHADOW |
| Filing Date | Monday, October 22, 1990 |
| Status | 600 - ABANDONED - INCOMPLETE RESPONSE |
| Status Date | Wednesday, July 22, 1992 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | angioplasty balloon catheters |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 044 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | SciMed Life Systems, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Maple Grove, MN 553697503 |
Trademark Events
| Event Date | Event Description |
| Wednesday, July 22, 1992 | ABANDONMENT - INCOMPLETE RESPONSE |
| Tuesday, June 9, 1992 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 10, 1991 | FINAL REFUSAL MAILED |
| Thursday, September 19, 1991 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 18, 1991 | NON-FINAL ACTION MAILED |
| Friday, February 15, 1991 | ASSIGNED TO EXAMINER |
